| 000 | 01038 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516222348.0 | ||
| 264 | 0 | _c20150511 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1547-6898 | ||
| 024 | 7 |
_a10.3109/10408444.2014.925424 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSlob, Wout | |
| 245 | 0 | 0 |
_aBenchmark dose and the three Rs. Part II. Consequences for study design and animal use. _h[electronic resource] |
| 260 |
_bCritical reviews in toxicology _cAug 2014 |
||
| 300 |
_a568-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBenchmarking |
| 650 | 0 | 4 | _aDatasets as Topic |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNo-Observed-Adverse-Effect Level |
| 650 | 0 | 4 | _aProbability |
| 650 | 0 | 4 | _aResearch Design |
| 773 | 0 |
_tCritical reviews in toxicology _gvol. 44 _gno. 7 _gp. 568-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10408444.2014.925424 _zAvailable from publisher's website |
| 999 |
_c23986482 _d23986482 |
||